Silver Book Fact

The increase in the stock of cancer drugs from 1975 to 1995 accounted for about 50 to 60 percent of the increase in age-adjusted survival rates in the first 6 years after diagnosis.

The Expanding Pharmaceutical Arsenal in the War on Cancer. NBER Working Paper Series Web site. http://www.nber.org/papers/w10328. Published 2004

Reference

Title
The Expanding Pharmaceutical Arsenal in the War on Cancer
Publication
NBER Working Paper Series
Publication Date
Published 2004
Authors
Lichtenberg, F
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Close to one third of all drugs currently in the biopharmaceutical pipeline are for cancer, with around 5,500 potential first-in-class cancer medicines in development.  
  • For women age 40 or older, timely mammograms could reduce breast cancer mortality by about 16%–compared to those who are not screened.  
  • The standard treatment for prostate cancer used to require radical prostatectomy. Now, less invasive therapies like brachytherapy have been shown to have equal outcomes with fewer side effects.  
  • 750 cancer-fighting medicines are currently in development.  
  • “If you had been diagnosed with chronic myeloid leukemia (CML) in 1999, chances were that you would not be alive today. Just 3 out of 10 patients survived for…